Exploration of acridine scaffold as a potentially interesting scaffold for discovering novel multi-target VEGFR-2 and Src kinase inhibitors

References

Page 1

	Year	Citations
Discovery of <i>N</i>-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays Louis J. Lombardo, Francis Y. Lee, Ping Chen, Journal of Medicinal Chemistry Drug TargetPreclinical AssaysPharmacotherapyCompound 13Pharmaceutical Chemistry	2004	1.3K
<i>N</i>-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2<i>H</i>-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally Available, Dual-Specific c-Src/Abl Kinase Inhibitor Laurent Hennequin, J M Allen, J. Breed, Journal of Medicinal Chemistry Drug TargetPharmacotherapyPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry	2006	358
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. Fortunato Ciardiello, Rosa Caputo, Vincenzo Damiano, PubMed	2003	329
Mechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis Ganapati H. Mahabeleshwar, Weiyi Feng, Kumar B. Reddy, Circulation Research Endothelial CellsImmunologyCellular PhysiologyAngiogenesisMatrix Biology	2007	294
A Multicenter Phase II Trial of ZD6474, a Vascular Endothelial Growth Factor Receptor-2 and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Previously Treated Metastatic Breast Cancer Kathy D. Miller, José Trigo, Catherine Wheeler, Clinical Cancer Research	2005	197
Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors Yasushi Miyazaki, Jun Tang, Yutaka Maeda, Bioorganic & Medicinal Chemistry Letters	2005	153
Novel 4‐Amino‐furo[2,3‐d]pyrimidines as Tie‐2 and VEGFR2 Dual Inhibitors. Yasushi Miyazaki, et al. et al. ChemInform Molecular PharmacologyMedicinal ChemistryAbstract AlgebraAbstract AnalysisVegfr2 Dual Inhibitors	2005	116
ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells Siddik Sarkar, Abhijit Mazumdar, Rupesh Dash, Cancer Biology & Therapy	2010	95
A support vector machines approach for virtual screening of active compounds of single and multiple mechanisms from large libraries at an improved hit-rate and enrichment factor Lianyi Han, Xiangyang Ma, Honghuang Lin, Journal of Molecular Graphics and Modelling Targeted LibraryMedicinal ChemistryVirtual ScreeningLarge LibrariesHit Identification	2008	82
Acridine/acridone: a simple scaffold with a wide range of application in oncology Philippe Belmont, Ismet Dorange Expert Opinion on Therapeutic Patents Pharmaceutical ChemistryDna AffinityTumor BiologyMolecular PharmacologyMedicinal Chemistry	2008	76

Page 1